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ABSTRACT
DNA methylation and histone modifications play
a central role in the epigenetic regulation of gene
expression and cell differentiation. Recently, Np95
(also known as UHRF1 or ICBP90) has been found
to interact with Dnmt1 and to bind hemimethylated
DNA, indicating together with genetic studies a
central role in the maintenance of DNA methylation.
Using in vitro binding assays we observed a
weak preference of Np95 and its SRA (SET- and
Ring-associated) domain for hemimethylated CpG
sites. However, the binding kinetics of Np95 in
living cells was not affected by the complete loss
of genomic methylation. Investigating further links
with heterochromatin, we could show that Np95
preferentially binds histone H3 N-terminal tails
with trimethylated (H3K9me3) but not acetylated
lysine 9 via a tandem Tudor domain. This domain
contains three highly conserved aromatic amino
acids that form an aromatic cage similar to the
one binding H3K9me3 in the chromodomain of
HP1ß. Mutations targeting the aromatic cage of
the Np95 tandem Tudor domain (Y188A and Y191A)
abolished specific H3 histone tail binding. These
multiple interactions of the multi-domain protein
Np95 with hemimethylated DNA and repressive
histone marks as well as with DNA and histone
methyltransferases integrate the two major
epigenetic silencing pathways.
INTRODUCTION
DNA methylation and histone modiﬁcations are crucially
involved in the regulation of gene expression, inheritance
of chromatin states, genome stability and diﬀerentiation
(1–3). Although the biochemical networks controlling
these epigenetic marks have been the subject of intensive
investigation, their interconnection is still not well
resolved in mammals. DNA methylation patterns are
established by de novo DNA methyltransferases Dnmt3a
and 3b, while Dnmt1 is largely responsible for maintaining
genomic methylation after DNA replication (4,5). Dnmt1
possesses an intrinsic preference for hemimethylated
DNA substrates (6,7) and associates with proliferating
cell nuclear antigen (PCNA) at replication sites in vivo
(8–10). The transient interaction of Dnmt1 with PCNA
enhances methylation eﬃciency but is not strictly
required to maintain genomic methylation in human and
mouse cells (11,12).
Recently, Np95 has emerged as a central regulatory
factor for DNA methylation and interacts with all three
Dnmts (13). Np95 localizes at replication foci and its
genetic ablation leads to genomic hypomethylation and
developmental arrest (14–19). Np95 and its SET- and
Ring- associated (SRA) domain were shown to bind
hemimethylated DNA with higher aﬃnity than corre-
sponding symmetrically methylated or unmethylated
sequences both in vitro and in vivo (17,18,20–22). In
addition, crystal structures of the SRA domain com-
plexed with hemimethylated oligonucleotides revealed
ﬂipping of the 5-methylcytosine out of the DNA double
helix, a conﬁguration that would stabilize the SRA–DNA
interaction (20–22). Thus, recruitment of Dnmt1 to
hemimethylated CpG sites by Np95 has been proposed
as mechanism for the maintenance of genomic
methylation.
In addition to its role in controlling DNA methylation,
Np95 has been shown to take part in several other
chromatin transactions. Np95 or its human homolog
ICBP90/UHRF1 were reported to interact with the
histone deacetylase HDAC1 and the histone methyl-
transferase G9a and to mediate silencing of a viral
promoter, suggesting a role of Np95 in gene silencing
through histone modiﬁcation (13,23,24). Np95 binds
histone H3 and displays a Ring domain-mediated E3
ubiquitin ligase activity for core histones in vitro and
possibly histone H3 in vivo (25,26). The plant
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decondensation of replicating pericentric heterochromatin
(PH), but it is still unclear which domains recognize
speciﬁc histone modiﬁcations (16,26,27).
In this study we systematically analyzed the binding
properties of Np95 and its individual domains to DNA
and histone tails in vitro and their binding kinetics in living
cells. Our data reveal a multi-functional modular structure
of Np95 interconnecting DNA methylation and histone
modiﬁcation pathways.
MATERIALS AND METHODS
Expression constructs
Expression construct for GFP–Dnmt1 and RFP–PCNA
were described previously (10,28,29). All Np95 constructs
were derived by PCR from corresponding myc- and
His6-tagged Np95 constructs (25). To obtain GFP–
and Cherry-fusion constructs the Dnmt1 cDNA in the
pCAG–GFP–Dnmt1-IRESblast construct (11) or the
pCAG–Cherry–Dnmt1–IRESblast was replaced by Np95
encoding PCR fragments. The GFP–Np95Tudor
expression construct was derived from the GFP–Np95
construct by overlap extension PCR (30). The GFP–
Tudor mutant (Y188A, Y191A) was derived from the
GFP–Np95 construct by PCR-based mutagenesis (31).
All constructs were veriﬁed by DNA sequencing.
Throughout this study enhanced GFP (eGFP) or
monomeric Cherry (mCherry) constructs were used and
for simplicity referred to as GFP– or Cherry-fusions.
Cell culture, transfection and immunoﬂuorescence staining
HEK293T cells and embryonic stem cells (ESCs) were
cultured and transfected as described (11), with the excep-
tion that FuGENE HD (Roche) was used for transfection
of ESCs. The dnmt1
/ J1 ESCs used in this study are
homozygous for the c allele (4). For immunoﬂuorescence
staining, TKO ESCs were grown on cover slips, ﬁxed with
3.7% formaldehyde in PBS for 10min and permeabilized
with 0.5% Triton X-100 for 5min. After blocking with 3%
BSA in PBS for 1h endogenous Np95 was detected with a
polyclonal rabbit anti-Np95 serum (32). The secondary
antibody was conjugated to Alexa Fluor 568 (Molecular
Probes). Nuclear counterstaining was performed with
DAPI and cells were mounted in Vectashield (Vector
Laboratories). Images were obtained using a TCS SP5
AOBS confocal laser scanning microscope (Leica) using
a 63x/1.4NA Plan-Apochromat oil immersion objective.
Fluorophores were excited with 405 and 561nm lasers.
In vitro DNA binding assay
The in vitro DNA binding assay was performed as
described previously (33) with the following modiﬁcations.
Two diﬀerent double-stranded DNA probes were labeled
with distinct ﬂuorophores and used in direct competition
(see Supplementary Figures S3 and S6 for details).
DNA oligos were controlled for CG methylation state
by digestion with either a CG methylation-sensitive
(HpaII) or -insensitive (MspI) enzyme (Supplementary
Figure S4). For extract preparation 2mM MgCl2 and
1mg/ml DNaseI were included in the lysis buﬀer.
Extracts from 1-3 transfected 10cm plates were diluted
to 500-1000ml with immunoprecipitation (IP) buﬀer and
1mg of GFP–Trap (34) (ChromoTek, Germany) per ﬁnal
assay condition was added. After washing and equilibra-
tion beads were resuspended in 500ml of binding buﬀer
(20mM Tris-HCl pH 7.5, 150mM NaCl, 0.5mM
EDTA, 1mM DTT, 100ng/ml BSA). Two oligonucleotide
substrates were added to a ﬁnal concentration of 50nM
each and incubated at room temperature (RT) for 60min
with constant mixing. Fluorescence intensity measure-
ments were performed with a Tecan Inﬁnite M1000
plate reader using the following excitation/emission wave-
lengths: 490±10nm/511±10nm for GFP, 550±15nm/
580±15nm for ATTO550 and 650±10nm/670±10nm
for ATTO647N. Values were adjusted using standard
curves obtained with ATTO-dye coupled oligonucleotide
primers and puriﬁed GFP. Binding activity was expressed
as the ratio between the ﬂuorescent signals of bound
DNA probe and GFP fusion protein bound to the
beads, so that the signals from bound probes are
normalized to the amount of GFP fusion. Furthermore,
values were normalized using a control set of DNA probes
having identical sequences but distinct ﬂuorescent labels
(see Supplementary Figures S3 and S6 for details).
Peptide pull-down assay
Peptides were purchased as TAMRA conjugates (PSL,
Germany) and are listed in Supplementary Figure S7.
The peptide pull-down assay was performed analogously
to the DNA binding assay described above. After one-step
puriﬁcation of GFP fusion proteins with the GFP–Trap
(ChromoTek, Germany), the beads were equilibrated in
1ml IP buﬀer and resuspended in 500ml binding buﬀer
supplemented with 100ng/ml of BSA. Peptides were
added to a ﬁnal concentration of 0.74mM and the
binding reaction was performed at RT for 15min to
60min with constant mixing. The beads were washed
twice with 1ml of IP buﬀer and resuspended in 100mlo f
the same. Wavelengths for excitation and measurement of
TAMRA were 490±5nm and 511±5nm, respectively.
Fluorescence intensity measurements were adjusted using
standard curves from TAMRA coupled peptide and
puriﬁed GFP.
Live cell microscopy and ﬂuorescence recovery after
photobleaching analysis
Live cell imaging and ﬂuorescence recovery after photo-
bleaching (FRAP) analysis were performed as described
previously (11). For presentation, we used linear contrast
enhancement on entire images.
Statistical analysis
Results were expressed as mean±SEM. The diﬀerence
between two mean values was analyzed by Student’s
t-test and was considered to be statistically signiﬁcant in
case of P<0.05 and highly signiﬁcant with P<0.001.
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Un- and hemimethylated DNA substrates (1pmol
UMB550 and HMB647N, respectively) were incubated
with 0.6pmol puriﬁed GFP–Np95 and 0.4pmol
GFP–antibody (mouse monoclonal antibody, Roche).
Samples were subjected to a 3.5% non-denaturing
PAGE and analyzed with a ﬂuorescence scanner
(Typhoon Trio scanner; GE Healthcare) to detect
ATTO550 (unmethylated substrate), ATTO647N
(hemimethylated substrate) and green ﬂuorescence
(GFP–Np95).
RESULTS AND DISCUSSION
Np95 binding kinetics is largely independent of DNA
methylation levels in vivo
Recent studies showed Np95 bound to hemimethylated
DNA, suggesting that the essential function of Np95 in
the maintenance of DNA methylation consists of
substrate recognition and recruitment of Dnmt1. To inves-
tigate the dynamics of these interactions in vivo we
transiently transfected wild-type (wt) J1 ESCs with expres-
sion constructs for Cherry-Np95 and GFP–Dnmt1 and
monitored their subcellular distribution using live-cell
microscopy (Figure 1A and B). Np95 showed a nuclear
distribution with a cell cycle-dependent enrichment at
replicating PH, similar to Dnmt1. Consistent with earlier
observations (8,12,14–16) we detected co-localization of
Np95 and Dnmt1 at sites of DNA replication. We
investigated the dynamics of Np95 binding by quantitative
ﬂuorescence recovery after photobleaching (FRAP)
analysis (Figure 1B). As chromocenters (aggregates of
PH) are not homogeneously distributed in the nucleus,
we chose to bleach half nuclei to ensure that the
bleached region contains a representative number of
potential binding sites. We observed a relatively fast and
full recovery of relative GFP–Dnmt1 ﬂuorescence inten-
sity (Figure 1B), reﬂecting a transient and dynamic inter-
action as described before (11). In contrast, Cherry-Np95
showed a considerably slower and only partial (80%)
recovery within the same observation period. These
results indicated a relatively stable binding of Np95 to
chromatin and revealed an immobile protein fraction of
about 20%. These in vivo binding properties would be
consistent with tight binding of Np95 to hemimethylated
CpG sites and ﬂipping of the methylated cytosines out of
the DNA double helix as shown in recent co-crystal struc-
tures of the SRA domain of Np95 (20–22).
To directly test the contribution of DNA methylation
and the interaction with Dnmt1 to protein mobility, we
compared the binding kinetics of GFP–Np95 in wt ESCs
and ESCs lacking either Dnmt1 or all three major DNA
methyltransferases Dnmt1, 3a and 3b (triple knockout,
TKO). Surprisingly, Np95 binding to chromatin was not
aﬀected by either drastic reduction (dnmt1
/) or even
complete loss (TKO) of genomic methylation and
showed in both cases remarkably similar FRAP kinetics
compared to wt J1 ESCs (Figure 1C). Similar results were
obtained with a C-terminal GFP fusion (Np95-GFP;
Supplementary Figure S1), arguing against conforma-
tional or sterical impairments of the N-terminal fusion
protein that could aﬀect the binding kinetics. Also, both,
the levels of endogenous Np95 and its degree of accumu-
lation at chromocenters were highly variable in TKO cells,
with chromocenter accumulation clearly visible in some
cells (Supplementary Figure S2). These results show that
DNA methylation and the three DNA methyltransferases
do not have a major eﬀect on the overall binding kinetics
of Np95 in living cells.
The SRA domain of Np95 is necessary and suﬃcient for
DNA binding in vitro
Next, we investigated the DNA binding activity of Np95
and the contribution of distinct Np95 domains by
generating a systematic set of individual domains and
deletion constructs fused to GFP (Figure 2A). To
directly compare the in vitro binding aﬃnity of Np95
regarding diﬀerent methylation states, we synthesized
double-stranded DNA-binding substrates with either one
or three un- or hemimethylated CpG sites and labeled
them with two distinct ﬂuorophores (Supplementary
Figure S3). DNA probes were controlled for CG
methylation state by digestion with either a CG
methylation-sensitive (HpaII) or -insensitive (MspI)
enzyme (Supplementary Figure S4). Performing conven-
tional electrophoretic mobility shift and supershift assays
we conﬁrmed the DNA binding activity of Np95 and
detected a preference for hemimethylated DNA substrates
(Figure 2B and Supplementary Figure S5).
As a second line of evidence and to quantify binding
preferences, we applied our recently developed non-
radioactive DNA binding assay (33) and tested
GFP–fused wt Np95 as well as a systematic set of individ-
ual domains and deletion constructs for their DNA-
binding properties in vitro (Figure 2C and Supplementary
Figure S6). This assay allows fast comparison of diﬀerent
potential binding substrates in direct competition as
well as the simultaneous quantiﬁcation of GFP–labeled
protein to calculate relative binding activity. The diﬀerent
GFP–Np95 fusion constructs were expressed in HEK293T
cells, puriﬁed with the GFP–Trap (34) and incubated with
the ﬂuorescently labeled DNA substrates. GFP–fusion
protein and bound DNA substrates were quantiﬁed with
a ﬂuorescence plate reader (Figure 2C and Supplementary
Figure S6). Furthermore, results were corrected for any
bias due to incorporation of diﬀerent ﬂuorescent labels
(Supplementary Figures. S3 and S6). Under these assay
conditions we observed an up to 2-fold preference
(factor 1.6–1.9) of Np95 for DNA substrates containing
one or three hemimethylated CpG sites (Supplementary
Figure S6). Deletion of the SRA domain completely abol-
ished the DNA-binding activity of Np95, whereas deletion
of either the PHD or the Tudor domain had no eﬀect
(Figure 2C). Consistently, the isolated PHD and Tudor
domains did not bind to DNA, while the SRA domain
alone showed similar binding strength and sequence pref-
erence as full-length Np95. Together, these results clearly
demonstrate that the SRA domain of Np95 preferentially
binds to hemimethylated CpG sites, although this
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substrates in vitro.
The SRA domain dominates binding kinetics but not
localization of Np95
Next, we investigated the role of distinct Np95 domains
in nuclear interactions in vivo. To this aim, we expressed
the same GFP–Np95 constructs in np95
/ ESCs and
tested their binding kinetics with FRAP experiments
(Figure 2D). Importantly, GFP–Np95 showed similar
FRAP kinetics in Np95 deﬁcient, wt or Dnmt-deﬁcient
ESCs (Figures 1C and 2D). Among all domains tested,
only the SRA domain showed similar kinetics as
full-length Np95, including the relatively slow recovery
and an immobile fraction of about 20%, while the
Tudor and PHD domain displayed the same high
mobility as GFP. Also, FRAP curves of the corresponding
deletion constructs indicated that the Tudor and the PHD
domains have only a minor contribution to in vivo binding
kinetics, while deletion of the SRA domain drastically
increased the mobility of Np95. These data indicate that
the SRA domain dominates the binding kinetics of Np95
in vivo. Curiously, the addition of the PHD to the SRA
domain (GFP–PHD-SRA) resulted in intermediate
kinetics and loss of the immobile fraction. This eﬀect
was, however, not observed in the context of the
full-length protein, suggesting that nuclear interactions
of Np95 are controlled by a complex interplay among
its domains. To directly study the role of the SRA
domain in controlling the subcellular localization of
Np95 we co-transfected np95
/ ESCs with expression
constructs for Cherry-Np95 and either GFP–SRA or
GFP–Np95SRA (Figure 2E). This direct comparison
showed that the isolated SRA domain does not co-localize
with full-length Np95 at PH. Together, these results
indicate that the SRA domain of Np95 is necessary and
suﬃcient for DNA binding in vitro and also dominates the
binding kinetics in vivo, but is per se not suﬃcient for
proper subnuclear localization. The fact that the
Np95SRA construct co-localized with Np95 suggests
that other domains than the SRA control the subcellular
targeting of Np95.
Np95 binds to histone H3 via a tandem Tudor domain
Database searches showed that the sequence between the
Ubl and PHD domains of Np95 is highly conserved in
vertebrates and displays structural similarity to the
family of Tudor domains [(35); PDB 3db4; Figure 3A
and B]. The crystal structure revealed that the Tudor
domain is composed of two subdomains (tandem Tudor)
forming a hydrophobic pocket that accommodates a
histone H3 N-terminal tail trimethylated at K9
(H3K9me3) (PDB 3db3; Figure 3C). This hydrophobic-
binding pocket is created by three highly conserved
amino acids (Phe152, Tyr188, Tyr191) forming an
aromatic cage (Figure 3A and C). Interestingly, a very
similar hydrophobic cage structure has been described
for the chromodomain of the heterochromatin protein
1ß (HP1ß) (Supplementary Figure S7) that is known to
bind trimethylated lysine 9 of histone H3 and associates
with PH (36).
To further investigate the histone tail-binding properties
of Np95, we mutated two amino acids of the aromatic
cage (Y188A, Y191A) and tested the isolated tandem
Tudor domain and corresponding mutant in comparison
with Np95 using a peptide binding assay. GFP–Np95,
GFP–Tudor and GFP–Tudor (Y188A, Y191A) were
expressed in HEK293T cells, puriﬁed with the GFP–
Trap and incubated with TAMRA-labeled histone tail
peptides. The ﬂuorescence intensity of GFP fusion
proteins and bound peptides was quantiﬁed and the
relative binding activity calculated (Figure 3D and
Supplementary Figure S7). The tandem Tudor domain
showed a highly signiﬁcant preference for the trimethy-
lated (H3K9me3) peptide, while this eﬀect was less pro-
nounced in the full-length Np95. Interestingly, acetylation
of K9 (H3K9ac), a modiﬁcation largely underrepresented
in silent chromatin, prevented binding of the tandem
Tudor domain. Remarkably, point mutations targeting
aromatic cage residues within the tandem Tudor domain
completely abolished speciﬁc binding to N-terminal
histone H3 peptides.
Consistent with these binding data the tandem Tudor
domain also showed a weak enrichment at PH, while the
PHD domain, previously proposed as potential histone
H3-binding motif (26), did neither bind to H3K9
peptides in vitro nor to PH in vivo (Supplementary
Figure S8). These results indicate that the tandem Tudor
domain of Np95 features a peptide binding pocket with
structural and functional striking similarity to HP1ß and
confers selective binding to histone modiﬁcation states
associated with silent chromatin.
These multiple interactions of Np95 with heterochro-
matin components correlate well with functional data.
The depletion of Np95 in mouse cells resulted in increased
transcription of major satellite repeats (16). Also, an inter-
action of Np95 with G9a was described and both were
found to be essential for transcriptional regulation (24)
and epigenetic silencing of transgenes (13).
In summary, we showed that the SRA domain is neces-
sary and suﬃcient for DNA binding of Np95 in vitro.
Photobleaching experiments further indicated that the
SRA domain also dominates the binding kinetics of
Np95 in living cells which was however largely indepen-
dent of the DNA methylation level. These results suggest
that the SRA domain may also bind to unmethylated
DNA or undergo additional, still unidentiﬁed interactions
in vivo. While the essential role of Np95 in the mainte-
nance of DNA methylation is well established, it is still
unclear how a relatively weak preference for hemimethy-
lated DNA can be suﬃcient to maintain DNA methyla-
tion patterns over many cell division cycles for an entire
life time. We suggest that the multiple interactions of
the multi-domain protein Np95 with hemimethylated
DNA and H3K9 methylated histone tails as well as with
histone (G9a) and DNA (Dnmt1, 3a and 3b) methyl-
transferases may add up to the necessary speciﬁcity
in vivo. Clearly, these multiple interactions place Np95 at
the center of various epigenetic silencing mechanisms and
likely mediate epigenetic crosstalk.
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the tandem Tudor domain are black shaded, while positions showing conservative substitutions are boxed with residues in bold face.
Secondary-structure elements were generated with EsPript (37) using the crystal structure of human UHRF1 (PDB 3db3 and 3db4) and are
shown above the amino acid sequence: a-helices (g), b-strands, strict alpha turns (TT) and strict beta turns (TTT). Accession numbers: Homo
sapiens Q96T88.1; Pan troglodytes XP_001139916.1; Bos Taurus AAI51672.1; Mus musculus Q8VDF2.2; Rattus norvergicus Q7TPK1.2; Dario rerio
NP_998242.1; Xenopus laevis ABY28114.1, Gallus gallus XP_418269.2. (B) Side view of the tandem Tudor domain as a cartoon model (left) and as
surface representation (right) in complex with a histone H3 N-terminal tail peptide trimethylated at lysine 9 (green stick model; only Arg8-Lys9-Ser10
of the H3 peptide are resolved). The image was generated with PyMOL (38). (C) An aromatic cage is formed by Phe152, Tyr188 and Tyr191 and
accommodates the trimethylated lysine 9 of H3 (H3K9me3). (D) Histone H3 N-terminal tail binding speciﬁcity of GFP–Np95, GFP–Tudor and
GFP–Tudor (Y188A Y191A) in vitro. Shown are ﬂuorescence intensity ratios of bound probe/bound GFP fusion. GFP was used as negative control.
Shown are means±SEM from four to ten independent experiments and two-sample t-tests were performed that do or do not assume equal
variances, respectively. Statistical signiﬁcance compared to the binding ratio of H3K9me3 is indicated: *P<0.05, **P<0.001.
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